Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant in Primary Insomnia (Study B)
NCT01097629Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- May 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of suvorexant in Insomnia, sponsored by Merck & Co.. Started May 2010; status: completed.
02
Drugs
suvorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT01097629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01097629.